Ian Douglas Walker

Title: Ian Douglas Walker: Innovator in Mycoplasma Vaccines

Introduction

Ian Douglas Walker is a notable inventor based in Parkville, Australia. He has made significant contributions to the field of immunology, particularly in the development of vaccines against Mycoplasma infections. His work is characterized by a focus on creating effective immunogens that can be utilized in vaccine preparations.

Latest Patents

Ian Douglas Walker holds a patent for "Mycoplasma recombinant polypeptides and vaccines." This invention relates to immunogens and their application in vaccine formulations. Specifically, it involves peptides or polypeptides that correspond to, mimic, or cross-react with B-cell or T-cell epitopes on surface polypeptides encoded by Mycoplasma species. The immunogens developed through this invention are particularly valuable for both prophylactic and therapeutic treatments against Mycoplasma infections. Additionally, the patent provides diagnostic reagents for detecting Mycoplasma in biological samples from individuals suspected of infection.

Career Highlights

Ian is affiliated with the University of Melbourne, where he continues to advance research in immunology and vaccine development. His work has garnered attention for its potential impact on public health, particularly in combating infections caused by Mycoplasma species.

Collaborations

Ian has collaborated with esteemed colleagues, including Michael Francis Duffy and Glenn Francis Browning. These partnerships have contributed to the advancement of research and innovation in the field of immunology.

Conclusion

Ian Douglas Walker is a prominent inventor whose work in Mycoplasma vaccines showcases his commitment to improving health outcomes through innovative research. His contributions to the field are significant and continue to influence vaccine development strategies.